-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A research team led by Nankai University recently published a paper titled "Targeted Repair of Vascular Injury by Adipose-Derived Stem Cells Modified with P-Selectin Binding Peptide" in Advanced Science.
Cardiovascular diseases, including coronary artery obstruction, have become the number one killer of human health
Adipose-derived stem cells (ADSC) have become the main source of cells for tissue engineering and regenerative medicine because they are easy to isolate and self-renew
DPP modification
In this study, the researchers combined P-selectin-binding peptide (PBP) with polyethylene glycol-conjugated phospholipid derivative (DMPE-PEG) through the hydrophobicity between DMPE-PEG and the phospholipid bilayer.
After identifying this DPP (DMPE-PEG-PBP) modification, they first evaluated the effect of the modification on the behavior of ADSCs
Targeting of DPP-ADSC
Next, the researchers evaluated the targeting ability of DPP-ADSC in vitro and in vivo
In vivo experiments, guidewire-mediated injury of rat femoral arteries induced luminal expression of P-selectin
DPP-ADSC repair arterial injury
Afterwards, the researchers injected 5 × 10 −6 M DPP-ADSC into a rat femoral artery injury model by intravenous injection to evaluate its repair effect
In theory, the ideal way to repair damaged arteries is to restore their original physiological structure
When evaluating the repair mechanism of DPP-ADSC, they found that DPP-ADSC adheres to the surface of the damaged blood vessel, reduces the further adhesion of white blood cells and platelets, reduces the local inflammatory response, and effectively inhibits the intimal proliferation of the damaged blood vessel
Finally, the researchers also evaluated the targeting ability of DPP-ADSC in a human femoral artery balloon injury model
in conclusion
In summary, the research team successfully used DPP to modify the cell membrane surface of ADSCs, and fully confirmed that ADSCs modified with 5 × 10 −6 M DPP have stronger targets for activated platelets, activated endothelial cells and damaged blood vessels.
Original Search
Yan H, Mi X, Midgley AC, Du X, Huang Z, Wei T, Liu R, Ma T, Zhi D, Zhu D, Wang T, Feng G, Zhao Y, Zhang W, He J, Zhu M, Kong D , Wang K.